BioHealth Innovation
If you are having trouble viewing this email, please click here

February 12, 2019




Submit your application by March 1st for a chance to be named

‘the company with the most commercial potential’

at the BioHealth Capital Region Forum 

Deadline for entries is March 1, 2019

Finalists will be announced March 21, 2019

Present at BioHealth Capital Region Forum April 9, 2019.

Finalists will have a chance to win the grand prize by presenting in front of a panel of world-class judges.


Grand Prize provided by WSGR $10,000

Visibility in front of hundreds of industry leaders and prominent industry funding experts and executives.


Product, Technical Feasibility, Marketing/Strategy, Leadership Team, Financial/Projection


Read More

Startup CXO Database

Are you an experienced biohealth entrepreneur seeking new opportunities in the BioHealth Capital Region? BioHealth Innovation is developing a database of experienced industry personnel willing to work in potential C-suite positions with our university and startup partners. If you would like to have your contact information and vita included in this database for their review, please email BHI an updated vita by this Thursday, February 14th.

Read More

Brian Darmody Announced as AURP CEO & Launches ‘AURP HQ2’ in Washington, DC Area

The Association of University Research Parks (AURP), a professional association of university-related research and science parks, announced the appointment of Brian Darmody, Associate Vice President of Corporate Engagement at the University of Maryland (UMD), as its new Chief Executive Officer (CEO). Additionally, the association has opened a new office at the UMD Discovery District in the Washington, DC area, to be known as ‘AURP HQ2.’ Mr. Darmody will immediately assume his new role as CEO at the new location. He will continue his role at UMD and plans to transition out of UMD over time.

Read More

BioHealth Innovation Entrepreneur-in-Residence Feedback - Feb. 27th

Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan. Sign up now to schedule your feedback session with BHI EIRs on Wednesday, February 27th. (Next sessions scheduled for 3/20 and 5/22.) Pre-registration is required; sign up here (“EIR resource”at BHI). For questions/more information, contact BHI.

Read More

2-28 SBIR & Non-Dilutive Funding Workshop Agenda Set!

University of Maryland Institute for Bioscience & Biotechnology Research, 9600 Gudelsky Drive, Rockville, MD 20850

Register NOW:

  • 8:00 a.m. – Networking and Registration
  • 8:30 a.m. – Welcome
  • 8:35 a.m. – SBIR Funding Opportunities at the National Institutes of Health
    • National Heart, Lung, and Blood Institute
    • National Institute on Aging
    • National Institute on Drug Abuse
    • National Cancer Institute
  • 9:45 a.m. – Partnership Opportunities with NCI Frederick National Lab
  • 10:00 a.m. – BREAK
  • 10:20 a.m. – SBIR Funding Opportunities with the National Science Foundation
  • 11:00 a.m. – BREAK
  • 11:15 a.m. – SBIR Funding Opportunities with USAMRC
  • 11:45 a.m. – Lunch
  • 12:45 p.m. – (1:1 Room Set)
  • 1:00 p.m. – Writing Your Specific Aims Page OR 1:1 Meetings* (available simultaneously)
  • 1:30 p.m. – Writing Your Phase II Commercialization Plan OR 1:1 Meetings* (available simultaneously)
  • 2:00 p.m. – Writing Your Specific Aims Page OR 1:1 Meetings* (available simultaneously)
  • 2:30 p.m. – Writing Your Phase II Commercialization Plan OR 1:1 Meetings* (available simultaneously))
  • 3:00 p.m. – 1:1 Meetings* (NIH only)
  • 4:00 p.m. – Adjourn

Pre-Registration REQUIRED: RSVP by noon, February 26 at charge for entrepreneurs to attend • If seeking 1:1 meeting(s) please include organization(s) in RSVP.

Read More

MacroGenics' stock price more than doubles on successful breast cancer study - MedCity News

Shares of MacroGenics went stratospheric Wednesday following the release of data from a pivotal Phase III study of the company’s lead drug candidate in breast cancer that beat many investors’ expectations.

Read More

VLP Therapeutics to Initiate First Clinical Trial of VLPM01 Malaria Vaccine

VLP Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a clinical trial of the Company's VLPM01 malaria vaccine. The Phase I/IIa clinical trial will begin recruiting participants in February 2019, and is designed to assess the safety, immunogenicity and efficacy of the VLPM01 vaccine. The clinical trial will be conducted at the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, MD.

Read More

US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for MEDI8897, an extended half-life respiratory syncytial virus (RSV) F monoclonal antibody (mAb) being developed for the prevention of lower respiratory tract infection (LRTI) caused by RSV.

Read More

The United States Of Venture Capital: The Most Active VC In Each State

Although startups based in California, New York, and Massachusetts have traditionally accounted for the majority of VC tech investment in the US, VCs are spurring other hotbeds of innovation across the country.

Read More

New Lab Space Designed to Attract Biotech Talent and Community Opens at 704 Quince Orchard - BioBuzz

When construction is completed this month, 704 QO will offer ready-to-occupy lab/office spaces for companies of all sizes. What really makes this new building stand out isn’t just the fully customizable individual lab units, but the suite of amenities that are tailored to the specific needs of emerging life science companies in the BioHealth Capital Region and the employees that work for them.

Read More

Look back at 10 of Baltimore tech's biggest moments of the last decade - Baltimore

Today we’re celebrating around the Slack channel. It’s the 10th anniversary of’s founding in Philadelphia, marking a decade of local tech news and innovation community coverage.

Read More

PitchMasters™ hosts four emerging startups at January event, expands to Baltimore and New York - Shulman Rogers

PitchMasters™, a workshop-style event for entrepreneurs preparing for their first institutional capital raise, held its 2019 Kick Off and Alumni Event on Jan. 30, 2019. Four emerging startup companies, Skipiit, Trove Therapeutics, Uplift and VERALOX Therapeutics, practiced their pitching skills and gained insights from experienced entrepreneurs, investors, industry influencers and fellow PitchMasters™ alumni.

Read More

Growth In Life Sciences Innovation Triggers Demand For Real Estate Clusters

The life sciences industry is taking off, with the medical technology and biotech sectors expected to grow further as traditional pharmaceutical companies are joined by startups and incubator labs driving new research and development. And with life sciences innovation rising, so is demand for the space in which to innovate.

Read More

Beyond Wellness For the Healthy: Digital Health Consumer Adoption 2018 - Rock Health

Utilization of digital health services and technologies has been on the rise since we first began surveying the US adult population in 2015. Budding choices of wearables, apps, telemedicine, and other tech-enabled services make it easy for consumers to test out what it might be like to “go digital” for their health. In the first three years, our annual survey showed that tools for fitness and wellness represented a common (and low-risk) entry point for consumers to experiment with products that fit neatly into their already tech-enabled lifestyles. In the 2018 data that we examined for this report, we saw something different.

Read More

Home | About BHI | BHI News | Programs | Partners | Contact

Copyright © BioHealth Innovation 2017
All Rights Reserved.